Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors

Nutrition and Cancer

Volumn 62, Issue 4, 2010, Pages 436-442

  Slattery, Martha L ^a   Wolff, Roger K ^a   Herrick, Jennifer S ^a   Caan, Bette J ^b   Samowitz, Wade ^c  

^a UNIVERSITY OF UTAH   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; K RAS 2 PROTEIN; K RAS PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CALCIUM INTAKE; CANCER GENETICS; CODON; CONTROLLED STUDY; CPG ISLAND; DIETARY INTAKE; EPIGENETICS; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; LIFESTYLE; MAJOR CLINICAL STUDY; METHYLATION; RECTUM CANCER; SUN EXPOSURE;

ADULT; AGED; CALCIUM, DIETARY; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; GENES, P53; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; QUESTIONNAIRES; RAS PROTEINS; RECEPTORS, CALCITRIOL; RECTAL NEOPLASMS; SUNLIGHT; UNITED STATES; VITAMIN D;

EID: 77951990572     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903441204     Document Type: Article

References (41)

1. Shin A, Li H, Shu XO, Yang G, Gao YT, et al.: Dietary intake of calcium, fiber and other micronutrients in relation to colorectal cancer risk: results from the Shanghai Women's Health Study. Int J Cancer 119, 2938-2942, 2006.
2. Terry P, Baron JA, Bergkvist L, Holmberg L, and Wolk A: Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer 43, 39-46, 2002. (Pubitemid 35387254)
3. Kampman E, Giovannucci E, van't Veer P, Rimm E, Stampfer MJ, et al.: Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol 139, 16-29, 1994.
4. Martinez ME and Willett WC: Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7, 163-168, 1998.
5. Slattery ML, Neuhausen SL, Hoffman M, Caan B, Curtin K, et al.: Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer 111, 750-756, 2004.
6. Martinez ME and Jacobs ET: Calcium supplementation and prevention of colorectal neoplasia: lessons from clinical trials. J Natl Cancer Inst 99, 99-100, 2007.
7. Huncharek M, Muscat J, and Kupelnick B: Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26, 335 cases from 60 observational studies. Nutr Cancer 61, 47-69, 2009.
8. Lipworth L, Bender TJ, Rossi M, Bosetti C, Negri E, et al.: Dietary vitamin D intake and cancers of the colon and rectum: a case-control study in Italy. Nutr Cancer 61, 70-75, 2009.
9. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, et al.: Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of vitamin D intake mediated through VDR binding. Int J Cancer 123, 2170-2179, 2008.
10. Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, et al.: CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 2752-2755, 2007.
11. Wong HL, Seow A, Arakawa K, Lee HP, Yu MC, et al.: Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 24, 1091-1005, 2003.
12. Slattery ML, Wolff RK, Curtin K, Fitzpatrick F, Herrick J, et al.: Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res 660, 12-21, 2009.
13. Slattery ML, Potter J, Caan B, Edwards S, Coates A, et al.: Energy balance and colon cancer-beyond physical activity. Cancer Res 57, 75-80, 1997. (Pubitemid 27020333)
14. Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, et al.: Physical activity and colorectal cancer. Am J Epidemiol 158, 214-224, 2003.
15. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, et al.: Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129, 837-845, 2005.
16. Samowitz WS, Albertsen H, Sweeney C, Herrick J, Caan BJ, et al.: Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 98, 1731-1738, 2006.
17. Issa JP, Shen L, and Toyota M: CIMP, at last. Gastroenterology 129, 1121-1124, 2005.
18. Slattery ML, Yakumo K, Hoffman M, and Neuhausen S: Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control 12, 359-364, 2001.
19. Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, et al.: Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 15, 744-749, 2006.
20. Edwards S, Slattery ML, Mori M, Berry TD, Caan BJ, et al.: Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 140, 1020-1028, 1994.
21. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, et al.: A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94, 761-766, 1994.
22. Slattery ML and Jacobs D R J: Assessment of ability to recall physical activity of several years ago. Ann Epidemiol 5, 292-296, 1995.
23. Slattery ML, Edwards SL, Ma K.-N., Friedman GD, and Potter JD: Physical activity and colon cancer: a public health perspective. Ann Epidemiol 7, 137-145, 1997.
24. McDonald A, Van Horn L, Slattery M, Hilner J, Bragg C, et al.: The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc 91, 1104-1112, 1991.
25. Liu K, Slattery M, Jacobs D Jr, Cutter G, McDonald A, Van Horn, L., et al. A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis 4, 15-27, 1994.
26. Camp NJ and Slattery ML: Classification tree analysis: a statistical tool to investigate risk factor interactions with an example for colon cancer (United States). Cancer Causes Control 13, 813-823, 2002.
27. Slattery ML, Curtin K, Ma K, Edwards S, Schaffer D, et al.: Diet activity, and lifestyle associations with p53 mutationsincolon tumors. Cancer Epidemiol Biomarkers Prev 11, 541-548, 2002.
28. Slattery ML, Curtin K, Anderson K, Ma KN, Edwards S, et al.: Associations between dietary intake and Ki-ras mutations in colon tumors: a populationbased study. Cancer Res 60, 6935-6941, 2000.
29. Kuss O and McLerran D: A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Methods Programs Biomed 87, 262-269, 2007.
30. Oh K, Willett WC, Wu K, Fuchs CS, and Giovannucci EL: Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 165, 1178-1186, 2007. (Pubitemid 47233720)
31. Kampman E, Slattery ML, Caan B, and Potter JD: Calcium, vitamin D, sunshine exposure, dairy products, and colon cancer risk (United States). Cancer Causes Control 11, 459-466, 2000.
32. Pritchard RS, Baron JA, and Gerhardsson de Verdier M: Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev 5, 897-900, 1996.
33. Wu K, Willett WC, Fuchs CS, Colditz GA, and Giovannucci EL: Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94, 437-446, 2002.
34. Thomas MG, Tebbutt S, and Williamson RC: Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 33, 1660-1663, 1992.
35. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, et al.: Calcium, vitaminD, and apoptosisinthe rectal epithelium. Cancer Epidemiol Biomarkers Prev 14, 525-528, 2005.
36. Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, et al.: A compromise of colon and rectal somatic DNA alterations. Dis Colon Rectum 52, 1304-1311, 2009.
37. Hussain SP and Harris CC: p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res 428, 23-32, 1999.
38. Cho Y, Gorina S, Jeffrey PD, and Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355, 1994.
39. Shen YM, Troxel AB, Vedantam S, Penning TM, and Field J: Comparison of p53 mutations induced by PAH o-quinones with those caused by antibenzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection. Chem Res Toxicol 19, 1441-1450, 2006.
40. Slattery ML, Curtin K, Ma K, Schaffer D, Potter J, et al.: GSTM-1 and NAT2 and genetic alterations in colon tumors. Cancer Causes Control 13, 527-534, 2002.
41. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, et al.: Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92, 1831-1836, 2000.